Skip to main content
. Author manuscript; available in PMC: 2010 Apr 12.
Published in final edited form as: J Nutr Health Aging. 2008 Jun–Jul;12(6):401–409. doi: 10.1007/BF02982674

Table 3.

Included Studies with MMSE <24 (Subjects With Cognitive Impairment)

First Author
(Reference)
Year N Tot. N Inc. N Exp. N Con. Age?
(Mean)
ESs Outcomes (Mean) MMSE Type of Intervention Frequency
(Sessions/week)
Intensity
(Minutes/Session)
Duration ES
(Endurance)
ES
(Strength)
Study
QS
Alessi CA 1999 29 29 15 14 88 Endurance: Maximum Time Walked 13 RCT: Functional & Endurance Exercises 5 sessions/week 35–78 min./session 14 Weeks 0,4 N/A 17
Alessi CA 1995 65 65 33 32 85 Endurance: Maximum Time Walked 13 RCT: Mobility & Endurance Exercises 3–5 sessions/week ≥60 min./session 9 Weeks 0,5 N/A 15
Bastone AC 2004 40 37 19 18 78 Endurance: Gait Speed Strength: Knee Ext. 19 CT: Group Exercises (Strength & Mobility) 2 sesseions/week 60 min./session 20 Weeks 0,7 0,7 15
Baum EE 2003 20 20 11 9 88 Endurance: Timed-up-and-go 22 RCT: Group Endurance Exercises 3 sessions/week 60 min./session 20 Weeks 0,5 N/A 16
Buettner LL 1994 36 34 18 16 83 Strength: Grip Strength 6 RCT: Functional & Recreational Exercises 6 sessions/week 60 min./session 8 Weeks N/A 0,7 20
Chandler JM 1998 100 100 50 50 78 Endurance: Gait Speed Strength: Knee Ext. 24 RCT: Lower Body Resistance Training 3 sessions/week Not Specified 10 Weeks 0,5 0,4 19
Fiatarone MA 1994 100 51 25 26 87 Endurance: Gait Speed Strength: Knee Ext. 22 RCT: High-Intensity Resistance Exercises 3 sessions/week 45 min./session 10 Weeks 0,6 1,0 19
Lazowski DA 1999 68 65 35 30 81 Endurance: Gait Speed Strength: Knee Extension <24* CT: Isotonic & Seateds Endurance Exercise 3 sessions/week 45 min./session 16 Weeks 0,5 0,7 19
MacRae PG 1996 37 31 19 12 91 Endurance: Walking Time Strength: Grip Strength 20 CT: Mobility (Walk Endurance) 5 sessions/week 30 min./session 12 Weeks 0,3 0,1 15
McMurdo ME 1994 65 65 36 29 83 Strength: Quadriceps Max Contractile Force 15 RCT: Isotonic & Isometric Seated Exercises 2 sesseions/week 45 min./session 24 Weeks N/A 0,6 19
McMurdo ME 1993 49 41 15 26 81 Strength: Grip Strength <24 RCT: Isotonic & Endurance Seated Exercises 2 sesseions/week 45 min./session 28 Weeks N/A 0,8 16
Meuleman JR 2000 78 58 26 32 75 Endurance: 6-min Aerobics Strength: Isokinetic Strength 23 RCT: Resistance & Endurance Training 5 sessions/week 30 min./session 8 Weeks 0,5 0,6 17
Morris JN 1999 468 248 124 124 85 Endurance: 6-min Walk Test <24 RCT: Progressive Weight-Lifting, Walking, & Isotonic Exercises 3 sessions/week 60 min./session 40 Weeks 0,2 N/A 15
Pomeroy VM 1999 81 81 43 38 82 Endurance: 2-min Walk Test <24* RCT (Single-Blinded): Mobility Training 5 sessions/week 30 min./session 2 Weeks 0,6 N/A 18
Schnelle JF 2002 190 148 74 74 88 Endurance: Gait Distance Strength: Arm Curl 13 RCT (Single-Blinded): Functional Skills & Mobility Exercises 5 sessions/week ≥60 min./session 32 Weeks 0,1 0,6 20
Schnelle JF 1996 97 72 35 37 84 Endurance: Gait Speed Strength: Roe Time 10 RCT: Cardiovascular & Mobility Exercises 3 sessions/week 20–35 min./session 9 Weeks 0,5 0,8 18
Schnelle JF 1995 76 76 36 40 85 Endurance: Walking Endurance (Distance) 12 RCT: Functional Skills & Mobility Exercises 5 sessions/week 30–55 min./session 8 Weeks 0,5 N/A 16
Simmons SF 2004 89 89 45 44 88 Endurance: Gait Distance Strength: Bicep Curl 12 RCT: Functional Skills & Mobility Exercises 5 sessions/week Every 2 Hours 32 Weeks 0,3 0,5 19
Stamford BA 1974 17 17 9 8 68 Endurance: Heart Rate <24* RCT: Cardiovascular & Mobility Traning 5 sessions/week 6–20 min./session 12 Weeks 1,0 N/A 18
Tappen RM 2000 65 45 23 22 87 Endurance: 6-min Walk Test 11 RCT (Single-Blinded): Mobility Training 3 sessions/week 30 min./session 16 Weeks 0,5 N/A 18
Worm CH 2001 46 39 21 18 81 Endurance: Gait Speed Strength: Shoulder Abduction 24 RCT: Aerobic/s Endurance & Balance/Strength Exercise 2 sesseions/week 60 min./session 12 Weeks 0,8 1,0 19

Abbreviations: ES=Effect Size, MMSE = Mini-Mental State Exam, N/A = Not Applicable, N-Exp. = Number of Subjects in Experimental Group, N-Inc. = Number of Subjects Included from Study, N-Tot. = Total Number of Subjects, N-Con. = Number of Subjects in Control Group, QS = Quality Score, RCT = Randomized Controlled Trial, CT = Controlled Trial;

*

= Mean MMSE Not Reported by the Author or Cognitive Assessment Evaluated with an Equivalent Tool to the MMSE